News Center

We’re excited to share important updates to our Genomic Unity® Mitochondrial Disorders testing portfolio. This update expands coverage to 348...

We are excited to announce major enhancements to our Genomic Unity® Comprehensive Ataxia Analysis, Genomic Unity® Ataxia Repeat Expansion Analysis,...

We have expanded our clinical testing portfolio with the launch of two new germline assays designed to address the unique...

Hereditary cardiomyopathies and arrhythmias are major contributors to morbidity and mortality worldwide. Cardiomyopathy refers to primary disorders of the cardiac...

GenomeWeb recently wrote a profile on Genomic Unity 2.0® – the first commercially available test to incorporate third-generation long-read Oxford...

Just 13 days ago, June 22nd to be exact, the American College of Medical Genetics and Genomics (ACMG) published the...

Today we officially welcomed two new Illumina Novaseq XPlus sequencers with a company-wide ribbon cutting ceremony. We can’t wait to complete validation (already under way!)…

ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing. ...

Genomeweb | May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to...

January 12, 2021 Clinicians at Variantyx, a leader in high complexity hereditary disease testing, recently completed analysis of their 2,500th...